Cargando…
Mesenchymal stromal cell‐derived syndecan‐2 regulates the immune response during sepsis to foster bacterial clearance and resolution of inflammation
Sepsis is a life‐threatening process related to a dysregulated host response to an underlying infection, which results in organ dysfunction and poor outcomes. Therapeutic strategies using mesenchymal stromal cells (MSCs) are under investigation for sepsis, with efforts to improve cellular utility. S...
Autores principales: | Han, Junwen, Shi, Yuanyuan, Willis, Gareth, Imani, Jewel, Kwon, Min‐Young, Li, Gu, Ayaub, Ehab, Ghanta, Sailaja, Ng, Julie, Hwang, Narae, Tsoyi, Konstantin, El‐Chemaly, Souheil, Kourembanas, Stella, Mitsialis, S. Alex, Rosas, Ivan O., Liu, Xiaoli, Perrella, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766882/ https://www.ncbi.nlm.nih.gov/pubmed/34355516 http://dx.doi.org/10.1111/febs.16154 |
Ejemplares similares
-
‘Good things come in small packages’: Application of exosome-based therapeutics in neonatal lung injury
por: Willis, Gareth R, et al.
Publicado: (2017) -
Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency
por: Willis, Gareth R., et al.
Publicado: (2017) -
Intratracheal transplantation of trophoblast stem cells attenuates acute lung injury in mice
por: Han, Junwen, et al.
Publicado: (2021) -
Paving the Road for Mesenchymal Stem Cell-Derived Exosome Therapy in Bronchopulmonary Dysplasia and Pulmonary Hypertension
por: Yeung, Vincent, et al.
Publicado: (2019) -
Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
por: Willis, Gareth R., et al.
Publicado: (2018)